Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial

Abstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementi...

Full description

Bibliographic Details
Main Authors: Yuichi Tatsuno, Yoshinari Morimoto, Megumi Hayashi, Takatoshi Iida
Format: Article
Language:English
Published: Nature Portfolio 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-83122-2
_version_ 1818845356617629696
author Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
author_facet Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
author_sort Yuichi Tatsuno
collection DOAJ
description Abstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementia and without cognitive impairment. Ten patients with severe dementia and 10 without cognitive impairment were registered. The bispectral index (BIS) and normalized tissue hemoglobin index (nTHI), which reflects CBF using near-infrared spectroscopy, were measured. Midazolam was administered until a Modified Observer’s Assessment of Alertness/Sedation score of 2 was reached. The chi-squared, Mann–Whitney U, Wilcoxon signed-rank, and Friedman tests and multiple regression analysis were used for comparisons. Whereas a similar decline in BIS values was observed in both groups after midazolam administration (P < 0.018), there was a significant decrease by 9% in the nTHI of the dementia-positive group (P < 0.013). However, there was no significant difference in the nTHI between the dementia-positive and dementia-negative group according to the multiple regression analysis (P = 0.058). In the dementia-negative group, none of the measured values differed from the baseline values. In the dementia-positive group, sedation with midazolam resulted in a 9% decrease in the CBF.
first_indexed 2024-12-19T05:28:22Z
format Article
id doaj.art-14cd0029bf184bb3a575bee0f1375159
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T05:28:22Z
publishDate 2021-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-14cd0029bf184bb3a575bee0f13751592022-12-21T20:34:18ZengNature PortfolioScientific Reports2045-23222021-02-0111111210.1038/s41598-021-83122-2Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trialYuichi Tatsuno0Yoshinari Morimoto1Megumi Hayashi2Takatoshi Iida3Department of Critical Care Medicine and Dentistry, Graduate School of Dentistry, Kanagawa Dental UniversityDepartment of Critical Care Medicine and Dentistry, Graduate School of Dentistry, Kanagawa Dental UniversityDepartment of Critical Care Medicine and Dentistry, Graduate School of Dentistry, Kanagawa Dental UniversityDepartment of Critical Care Medicine and Dentistry, Graduate School of Dentistry, Kanagawa Dental UniversityAbstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementia and without cognitive impairment. Ten patients with severe dementia and 10 without cognitive impairment were registered. The bispectral index (BIS) and normalized tissue hemoglobin index (nTHI), which reflects CBF using near-infrared spectroscopy, were measured. Midazolam was administered until a Modified Observer’s Assessment of Alertness/Sedation score of 2 was reached. The chi-squared, Mann–Whitney U, Wilcoxon signed-rank, and Friedman tests and multiple regression analysis were used for comparisons. Whereas a similar decline in BIS values was observed in both groups after midazolam administration (P < 0.018), there was a significant decrease by 9% in the nTHI of the dementia-positive group (P < 0.013). However, there was no significant difference in the nTHI between the dementia-positive and dementia-negative group according to the multiple regression analysis (P = 0.058). In the dementia-negative group, none of the measured values differed from the baseline values. In the dementia-positive group, sedation with midazolam resulted in a 9% decrease in the CBF.https://doi.org/10.1038/s41598-021-83122-2
spellingShingle Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
Scientific Reports
title Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_full Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_fullStr Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_full_unstemmed Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_short Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_sort comparison of intravenous sedation using midazolam during dental treatment in elderly patients with without dementia a prospective controlled clinical trial
url https://doi.org/10.1038/s41598-021-83122-2
work_keys_str_mv AT yuichitatsuno comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT yoshinarimorimoto comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT megumihayashi comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT takatoshiiida comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial